In cancer‐induced bone pain model, NLRP3 inflammasome inhibitor MCC950 treatment restores the expression of NLRP3 inflammasome and significantly suppresses the upregulation of IL‐1β, attenuates mechanical allodynia.13 The gene discussed is NLRP3; the disease is cancer.